Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts

Abstract Anal squamous cell carcinoma (ASCC) is a rare tumor of the gastrointestinal tract. We aimed to compare the genetic backgrounds and their effect on clinical outcomes between Japanese and Caucasian patients with ASCC. Forty-one patients diagnosed with ASCC at the National Cancer Center Hospit...

Full description

Bibliographic Details
Main Authors: Takahiko Ito, Daisuke Takayanagi, Shigeki Sekine, Taiki Hashimoto, Yoko Shimada, Maiko Matsuda, Masayoshi Yamada, Ryuji Hamamoto, Tomoyasu Kato, Dai Shida, Yukihide Kanemitsu, Narikazu Boku, Takashi Kohno, Atsuo Takashima, Kouya Shiraishi
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-30624-w
_version_ 1797864690476384256
author Takahiko Ito
Daisuke Takayanagi
Shigeki Sekine
Taiki Hashimoto
Yoko Shimada
Maiko Matsuda
Masayoshi Yamada
Ryuji Hamamoto
Tomoyasu Kato
Dai Shida
Yukihide Kanemitsu
Narikazu Boku
Takashi Kohno
Atsuo Takashima
Kouya Shiraishi
author_facet Takahiko Ito
Daisuke Takayanagi
Shigeki Sekine
Taiki Hashimoto
Yoko Shimada
Maiko Matsuda
Masayoshi Yamada
Ryuji Hamamoto
Tomoyasu Kato
Dai Shida
Yukihide Kanemitsu
Narikazu Boku
Takashi Kohno
Atsuo Takashima
Kouya Shiraishi
author_sort Takahiko Ito
collection DOAJ
description Abstract Anal squamous cell carcinoma (ASCC) is a rare tumor of the gastrointestinal tract. We aimed to compare the genetic backgrounds and their effect on clinical outcomes between Japanese and Caucasian patients with ASCC. Forty-one patients diagnosed with ASCC at the National Cancer Center Hospital were enrolled and evaluated for clinicopathological features, human papillomavirus (HPV) infection, HPV genotypes, p16 expression, PD-L1, and association of p16 status with the efficacy of concurrent chemoradiotherapy (CCRT). Target sequencing for hotspot mutations in 50 cancer-related genes was performed using genomic DNA from 30 available samples. Of 41 patients, 34 were HPV-positive (among them, HPV 16 was predominant; 73.2%); 38 patients were p16-positive (92.7%); and 39 patients received CCRT, of whom 36 were p16-positive and three p16-negative. p16-positive patients showed better complete response than p16-negative patients. Among 28 samples, 15 showed mutations in PIK3CA, FBXW7, ABL1, TP53, and PTEN; no difference in mutation profiles between the Japanese and Caucasian cohorts was observed. Actionable mutations were detected in both Japanese and Caucasian patients with ASCC. Genetic backgrounds, such as the HPV 16 genotype and PIK3CA mutations, were common regardless of ethnicity. p16 status may be a prognostic biomarker for CCRT in Japanese patients with ASCC.
first_indexed 2024-04-09T22:57:13Z
format Article
id doaj.art-5c62401519fd4daea4e73cec0c6d0bf9
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T22:57:13Z
publishDate 2023-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5c62401519fd4daea4e73cec0c6d0bf92023-03-22T11:12:19ZengNature PortfolioScientific Reports2045-23222023-03-011311910.1038/s41598-023-30624-wComparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohortsTakahiko Ito0Daisuke Takayanagi1Shigeki Sekine2Taiki Hashimoto3Yoko Shimada4Maiko Matsuda5Masayoshi Yamada6Ryuji Hamamoto7Tomoyasu Kato8Dai Shida9Yukihide Kanemitsu10Narikazu Boku11Takashi Kohno12Atsuo Takashima13Kouya Shiraishi14Department of Gastrointestinal Medical Oncology, National Cancer Center HospitalDivision of Genome Biology, National Cancer Center Research InstituteDepartment of Clinical Pathology, National Cancer Center HospitalDepartment of Clinical Pathology, National Cancer Center HospitalDivision of Genome Biology, National Cancer Center Research InstituteDivision of Genome Biology, National Cancer Center Research InstituteEndoscopy Division, National Cancer Center HospitalDivision of Molecular Modification and Cancer Biology, National Cancer Center Research InstituteDepartment of Gynecology, National Cancer Center HospitalDepartment of Colorectal Surgery, National Cancer Center HospitalDepartment of Colorectal Surgery, National Cancer Center HospitalDepartment of Gastrointestinal Medical Oncology, National Cancer Center HospitalDivision of Genome Biology, National Cancer Center Research InstituteDepartment of Gastrointestinal Medical Oncology, National Cancer Center HospitalDivision of Genome Biology, National Cancer Center Research InstituteAbstract Anal squamous cell carcinoma (ASCC) is a rare tumor of the gastrointestinal tract. We aimed to compare the genetic backgrounds and their effect on clinical outcomes between Japanese and Caucasian patients with ASCC. Forty-one patients diagnosed with ASCC at the National Cancer Center Hospital were enrolled and evaluated for clinicopathological features, human papillomavirus (HPV) infection, HPV genotypes, p16 expression, PD-L1, and association of p16 status with the efficacy of concurrent chemoradiotherapy (CCRT). Target sequencing for hotspot mutations in 50 cancer-related genes was performed using genomic DNA from 30 available samples. Of 41 patients, 34 were HPV-positive (among them, HPV 16 was predominant; 73.2%); 38 patients were p16-positive (92.7%); and 39 patients received CCRT, of whom 36 were p16-positive and three p16-negative. p16-positive patients showed better complete response than p16-negative patients. Among 28 samples, 15 showed mutations in PIK3CA, FBXW7, ABL1, TP53, and PTEN; no difference in mutation profiles between the Japanese and Caucasian cohorts was observed. Actionable mutations were detected in both Japanese and Caucasian patients with ASCC. Genetic backgrounds, such as the HPV 16 genotype and PIK3CA mutations, were common regardless of ethnicity. p16 status may be a prognostic biomarker for CCRT in Japanese patients with ASCC.https://doi.org/10.1038/s41598-023-30624-w
spellingShingle Takahiko Ito
Daisuke Takayanagi
Shigeki Sekine
Taiki Hashimoto
Yoko Shimada
Maiko Matsuda
Masayoshi Yamada
Ryuji Hamamoto
Tomoyasu Kato
Dai Shida
Yukihide Kanemitsu
Narikazu Boku
Takashi Kohno
Atsuo Takashima
Kouya Shiraishi
Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
Scientific Reports
title Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
title_full Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
title_fullStr Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
title_full_unstemmed Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
title_short Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
title_sort comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between japanese and caucasian cohorts
url https://doi.org/10.1038/s41598-023-30624-w
work_keys_str_mv AT takahikoito comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT daisuketakayanagi comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT shigekisekine comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT taikihashimoto comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT yokoshimada comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT maikomatsuda comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT masayoshiyamada comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT ryujihamamoto comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT tomoyasukato comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT daishida comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT yukihidekanemitsu comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT narikazuboku comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT takashikohno comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT atsuotakashima comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts
AT kouyashiraishi comparisonofclinicopathologicalandgenomicprofilesinanalsquamouscellcarcinomabetweenjapaneseandcaucasiancohorts